Zoster Vestibular Disturbance - Causes, Treatment & When to See a Doctor

```html

What is Zoster Vestibular Disturbance?

Zoster vestibular disturbance (sometimes called herpes zoster oticus or Ramsay Hunt syndrome type II) occurs when the varicella‑zoster virus (VZV) reactivates in the cranial nerve VII (facial nerve) and the adjacent vestibulocochlear nerve (cranial nerve VIII). The virus causes inflammation of the inner ear structures that control balance, leading to vertigo, dizziness, imbalance, and often accompanying facial weakness or rash.

While the term “vestibular disturbance” refers specifically to the balance‑related symptoms, most patients experience a cluster of neurologic, auditory, and dermatologic findings. Prompt recognition is essential because early antiviral therapy can dramatically improve outcomes and reduce the risk of permanent hearing loss or facial paralysis.

Common Causes

VZV reactivation is the primary trigger, but several underlying factors increase the likelihood that the virus will involve the vestibular system. The most frequent contributors are:

• Primary varicella infection (chickenpox) – the virus remains dormant in dorsal root and cranial nerve ganglia after the initial illness.
• Immunosuppression – HIV infection, organ transplantation, chemotherapy, or chronic corticosteroid use.
• Advanced age – immune surveillance wanes after age 50, making reactivation more common.
• Stress or severe illness – physical stress can precipitate VZV reactivation.
• Diabetes mellitus – hyperglycemia impairs cellular immunity.
• Autoimmune diseases – e.g., systemic lupus erythematosus, which require immunomodulating drugs.
• Trauma to the ear or head – may disrupt the viral latency site.
• Previous ear surgery – can alter local anatomy and immunity.
• Radiation therapy to the head/neck – damages nerve tissue and local immune defenses.
• Smoking – chronic exposure to nicotine impairs mucosal immunity.

These factors do not cause vestibular disturbance directly; they create a setting in which VZV can reactivate and spread to the inner ear.

Associated Symptoms

Because the facial and vestibulocochlear nerves travel together, patients often have a mixture of the following:

• Vertigo or a spinning sensation – typically sudden, lasting minutes to hours.
• Dizziness or light‑headedness – may be accompanied by a feeling of “floating.”
• Unsteady gait or imbalance – especially when walking in the dark.
• Hearing loss – can be mild to profound, unilateral.
• Tinnitus – ringing or buzzing in the affected ear.
• Ear pain (otalgia) or fullness.
• Facial weakness or paralysis – may range from slight drooping to complete Bell’s palsy on the same side.
• Herpetic vesicular rash – classic “shingles” lesions in the ear canal, pinna, or the soft palate.
• Hyperacusis – increased sensitivity to sound.
• Nausea and vomiting – result from severe vertigo.

When to See a Doctor

Because the condition can lead to lasting hearing loss or permanent facial nerve damage, early medical evaluation is crucial. Seek care promptly if you experience any of the following:

• Sudden, severe vertigo or dizziness that does not improve within 24 hours.
• Unexplained unilateral hearing loss or ringing in the ear.
• Facial droop, inability to close the eye, or difficulty smiling on one side.
• Appearance of a rash or blisters around the ear, on the face, or in the mouth.
• Persistent vomiting or inability to keep fluids down.
• New onset of severe headache, especially if accompanied by fever.
• Any neurologic symptom (e.g., numbness, weakness) spreading beyond the face.

If you have a weakened immune system, diabetes, or are over 60, call your provider even for milder symptoms, as complications are more likely.

Diagnosis

Diagnosis is based on a combination of clinical findings and targeted tests.

Clinical Evaluation

• History – timing of rash, ear pain, and vertigo; recent illnesses or immunosuppressive therapy.
• Physical exam – inspection for vesicles, assessment of facial nerve function (House‑Brackmann scale), and bedside vestibular testing (head‑impulse, Dix‑Hallpike).

Specialist Tests

• Audiometry – determines type and degree of hearing loss.
• Electronystagmography (ENG) or videonystagmography (VNG) – evaluates eye movements to confirm vestibular dysfunction.
• Imaging – MRI with gadolinium may be ordered to exclude other causes (e.g., tumor, stroke) and to visualize nerve enhancement typical of VZV inflammation.
• Laboratory – PCR testing of vesicular fluid or ear discharge for VZV DNA confirms viral involvement, though treatment is usually started before results return.

Treatment Options

Management focuses on three goals: eradicate the virus, reduce inflammation, and support vestibular recovery.

Antiviral Therapy

• Acyclovir, Valacyclovir, or Famciclovir – oral or IV formulations. Standard regimens are 7–10 days; earlier initiation (<72 hours from symptom onset) yields the best outcomes (Mayo Clinic, 2023).

Corticosteroids

• Prednisone 60 mg daily with a taper over 10–14 days is commonly added to reduce nerve swelling. Evidence from randomized trials shows improved facial nerve recovery when combined with antivirals (Cleveland Clinic, 2022).

Pain and Symptom Relief

• Analgesics – acetaminophen or NSAIDs for ear pain.
• Antiemetics – ondansetron or promethazine for nausea.
• Vestibular suppressants – meclizine or diazepam may be used short‑term; avoid long‑term use as they can delay central compensation.

Facial Nerve Rehabilitation

• Physical therapy – facial exercises, massage, and electrical stimulation to prevent muscle contractures.
• Eye protection – lubricating eye drops and taping the eye closed at night to prevent corneal drying.

Home & Supportive Care

• Stay hydrated and maintain a low‑salt diet if nausea is prominent.
• Use a steady‑gaze technique (focus on a fixed point) to compensate for vertigo.
• Sleep with the head slightly elevated to reduce ear pressure.
• Avoid sudden head movements; use a cane or assistance when walking in low‑light locations.

Prevention Tips

Because zoster vestibular disturbance stems from reactivation of a dormant virus, complete prevention is not possible, but risk can be markedly reduced.

• Shingles (zoster) vaccine – Recombinant zoster vaccine (RZV, Shingrix) is >90 % effective at preventing shingles and its complications in adults ≥50 years (CDC, 2024). It is also recommended for immunocompromised adults.
• Maintain good immune health – balanced diet, regular exercise, adequate sleep, and management of chronic diseases (diabetes, hypertension).
• Avoid smoking and limit alcohol – both impair immune function.
• Prompt treatment of initial chickenpox – antiviral therapy in children with severe varicella reduces viral load and may lower long‑term reactivation risk.
• Stress management – mindfulness, yoga, or counseling can mitigate one trigger for reactivation.
• Hand hygiene – reduces transmission of VZV to susceptible contacts, especially pregnant women and immunocompromised individuals.

Emergency Warning Signs

Key Take‑aways

• Zoster vestibular disturbance is a reactivation of varicella‑zoster virus affecting the inner ear and facial nerve.
• Prompt antiviral and steroid therapy (ideally within 72 hours) greatly improves hearing and facial‑nerve outcomes.
• Recognize the combination of vertigo, unilateral ear symptoms, facial weakness, and a vesicular rash.
• Seek medical care quickly; refer to emergency services for red‑flag symptoms.
• Vaccination (Shingrix) and healthy immune habits are the most effective preventive measures.

For personalized evaluation, always consult a qualified health professional. The information above reflects current guidelines from reputable sources such as the Mayo Clinic, CDC, NIH, WHO, and peer‑reviewed literature.

```